Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists

All categories
Name
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Accession Number
DBCAT004369
Description

Not Available

Drugs
DrugDrug Description
IvabradineA HCN channel blocker used to reduce the risk of hospitalization for worsening heart failure in adult patients and for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy in pediatric patients.
Drugs & Drug Targets
DrugTargetType
IvabradineCytochrome P450 3A4enzyme
IvabradinePotassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2target